Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma
about
Platinum-induced hearing loss after treatment for childhood cancerEnergy metabolism in neurodevelopment and medulloblastomaHearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood CancerRecommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment.Effect of Sensorineural Hearing Loss on Neurocognitive Functioning in Pediatric Brain Tumor Survivors.Craniospinal irradiation using helical tomotherapy for central nervous system tumors.Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupDefining the role of proton therapy in the optimal management of paediatric patients in Australia and New Zealand.Monitoring and Assessment of Neuropsychological Outcomes as a Standard of Care in Pediatric Oncology.Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.Posterior fossa syndrome: Review of the behavioral and emotional aspects in pediatric cancer patients.Attention, processing speed, and executive functioning in pediatric brain tumor survivors treated with proton beam radiation therapy.Ototoxicity monitoring in children treated with platinum chemotherapy.Do we still need IQ-scores? Misleading interpretations of neurocognitive outcome in pediatric patients with medulloblastoma: a retrospective study.Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy.Immunotherapy for brain tumors: understanding early successes and limitations.Intellectual, educational, and situation-based social outcome in adult survivors of childhood medulloblastoma.Attention-mediated neurocognitive profiles in survivors of pediatric brain tumors: Comparison to children with neurodevelopmental ADHD.Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.Early intervention for infants and toddlers: Applications for pediatric oncology.Disrupted development and integrity of frontal white matter in patients treated for pediatric medulloblastoma.Neurocognitive and Psychosocial Outcomes in Pediatric Brain Tumor Survivors
P2860
Q26470526-D23E6129-FE30-48A7-B1A1-B8025C0D8833Q26770345-B011851C-365C-4CBC-B01A-D0CBB5D74854Q30368168-3327E219-7512-44D3-BDF0-742E8C9DCB18Q30428790-ECA1448B-39CE-416B-98F8-CF509909606CQ30676878-4B5F5AE2-0BE2-4025-94A7-A56742CC33C7Q30700156-13DABEF6-5BBD-4C95-9F5F-9CCA1AC2FC4BQ33438507-7F7FFAB6-7AB2-409A-9145-6576A5FB1E08Q33922193-9BC8AC71-CCB7-458C-92C2-B2154F93D521Q38588047-05CEA97E-8FEA-4BB6-9D74-75E68C6426D7Q38678301-A362F849-EDE0-446F-91CD-8A31FDF3166EQ38784807-CCF5FCE5-3E59-4CE0-8A03-A6995267BD79Q38838969-BE178B55-1D9F-40E4-9B08-D460EA915C4EQ38992655-1D99B6C9-D0A6-46EC-AEF9-716C0CDE4E41Q39308843-1326A4BD-AF69-454B-9ECA-4B868C3BEC65Q39453840-E1E54EF4-1E8A-415B-95EE-059A65F7F191Q43603078-E2F0CE17-8C33-4CBA-95B3-2FF0599676CAQ47198919-949624DA-9D96-4566-AA80-18558EDECFADQ47555498-9DCABE07-FE27-4A66-BB7E-FE1FF6472224Q47559092-6B39348C-177B-44EF-B4EC-37892E92A72EQ47826935-88DFA17D-928C-4015-A521-A9D0776A433CQ48025865-5CAEA5F3-4B85-4DFC-AFD2-193860CF1B14Q48146713-3C80B94A-2A92-4BA2-8B8B-E251CE3DB9A5Q48357822-78D0E023-FC21-4C47-A757-7D147ECC2410Q50582289-21837AE5-7E56-4A93-9858-9D4C4B474A3AQ58749511-FFEA7BCF-C213-4272-8579-D605D1866CCD
P2860
Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Examination of risk factors fo ...... for pediatric medulloblastoma
@ast
Examination of risk factors fo ...... for pediatric medulloblastoma
@en
type
label
Examination of risk factors fo ...... for pediatric medulloblastoma
@ast
Examination of risk factors fo ...... for pediatric medulloblastoma
@en
prefLabel
Examination of risk factors fo ...... for pediatric medulloblastoma
@ast
Examination of risk factors fo ...... for pediatric medulloblastoma
@en
P2093
P2860
P50
P356
P1433
P1476
Examination of risk factors fo ...... for pediatric medulloblastoma
@en
P2093
Amar Gajjar
Carol L Armstrong
Donald J Mabbott
James G Gurney
Jane E Schreiber
Mary L Chapieski
Melanie J Bonner
Michelle Swain
Mingjuan Wang
Robyn Boyle
P2860
P304
P356
10.1093/NEUONC/NOU006
P577
2014-02-03T00:00:00Z